← Back to Search

Silk Scaffold Surgical Incision Dressing (SSSID Trial)

Phase 1
Waitlist Available
Led By Mehrdad Mark Mofid, M.D.
Research Sponsored by Mehrdad Mark Mofid
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 days post operation, 7 days post operation, 14 days post operation, 28 days post operation, 42 days post operation
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new silk-based wound dressing with medical adhesive on patients having cosmetic or reconstructive surgery. It aims to see how well the silk dressing helps in healing compared to other dressings. Patients will have different dressings on each side of their incision to directly compare results. Silk dressing materials have been used for treating burn wounds and have shown promising results in wound healing.

Eligible Conditions
  • Surgical Incisions

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 days post operation, 7 days post operation, 14 days post operation, 28 days post operation, 42 days post operation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 days post operation, 7 days post operation, 14 days post operation, 28 days post operation, 42 days post operation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dermatitis
Secondary study objectives
Wound Dressing Detachment
Other study objectives
Presence of Infection

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Surgical IncisionExperimental Treatment3 Interventions
Abdominoplasty Surgical Incision, Breast Reduction Surgical Incision, Mastopexy Surgical Incision, or Belt Lipectomy Surgical Incision
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
silk
2022
Completed Phase 1
~80
Dermabond Prineo Skin Closure System
2022
Completed Phase 1
~80
3M Steri-Strip
2022
Completed Phase 1
~80

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Mehrdad Mark MofidLead Sponsor
Mehrdad Mark Mofid, M.D.Principal InvestigatorSan Diego Skin
~24 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top